U.S. Physical Therapy (NYSE:USPH) Sets New 52-Week Low - What's Next?

U.S. Physical Therapy, Inc. (NYSE:USPH - Get Free Report)'s stock price hit a new 52-week low during trading on Monday . The stock traded as low as $69.99 and last traded at $70.70, with a volume of 2506 shares traded. The stock had previously closed at $71.93.

Analysts Set New Price Targets

Several equities analysts recently weighed in on the company. StockNews.com downgraded U.S. Physical Therapy from a "hold" rating to a "sell" rating in a research note on Friday, February 28th. JPMorgan Chase & Co. dropped their price target on U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating for the company in a research report on Wednesday, March 19th. Bank of America upgraded shares of U.S. Physical Therapy from a "neutral" rating to a "buy" rating and boosted their price objective for the stock from $100.00 to $115.00 in a research report on Monday, December 16th. Citizens Jmp raised shares of U.S. Physical Therapy to a "strong-buy" rating in a research note on Monday, December 16th. Finally, William Blair restated a "market perform" rating on shares of U.S. Physical Therapy in a research report on Thursday, February 27th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, U.S. Physical Therapy currently has an average rating of "Moderate Buy" and an average price target of $109.00.

Remove Ads

U.S. Physical Therapy Trading Down 5.4 %

The business has a 50-day moving average of $81.77 and a 200 day moving average of $86.22. The stock has a market cap of $1.04 billion, a PE ratio of 73.00, a PEG ratio of 3.54 and a beta of 1.37. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.78 and a current ratio of 1.78.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last issued its quarterly earnings results on Wednesday, February 26th. The company reported $0.65 EPS for the quarter, missing analysts' consensus estimates of $0.69 by ($0.04). The firm had revenue of $180.45 million for the quarter, compared to analysts' expectations of $173.10 million. U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. Equities research analysts predict that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current fiscal year.

U.S. Physical Therapy Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Shareholders of record on Friday, March 14th will be paid a dividend of $0.45 per share. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.62%. The ex-dividend date is Friday, March 14th. This is a positive change from U.S. Physical Therapy's previous quarterly dividend of $0.44. U.S. Physical Therapy's dividend payout ratio is currently 97.83%.

Insider Transactions at U.S. Physical Therapy

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,730 shares of the firm's stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $82.11, for a total value of $142,050.30. Following the sale, the chief operating officer now directly owns 7,168 shares of the company's stock, valued at approximately $588,564.48. This trade represents a 19.44 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 1.70% of the company's stock.

Institutional Investors Weigh In On U.S. Physical Therapy

A number of institutional investors have recently bought and sold shares of the stock. CBIZ Investment Advisory Services LLC grew its stake in shares of U.S. Physical Therapy by 59.8% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company's stock valued at $29,000 after buying an additional 122 shares during the period. Point72 Asia Singapore Pte. Ltd. acquired a new stake in U.S. Physical Therapy during the fourth quarter worth about $39,000. Venturi Wealth Management LLC increased its stake in U.S. Physical Therapy by 3,200.0% during the fourth quarter. Venturi Wealth Management LLC now owns 726 shares of the company's stock worth $64,000 after acquiring an additional 704 shares during the last quarter. Lazard Asset Management LLC purchased a new position in shares of U.S. Physical Therapy in the 4th quarter worth about $84,000. Finally, Pacer Advisors Inc. acquired a new position in shares of U.S. Physical Therapy in the 4th quarter valued at about $113,000.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.